Cherian M G, Miles E F, Clarkson T W, Cox C
Department of Pathology, University of Western Ontario, London, Canada.
J Pharmacol Exp Ther. 1988 May;245(2):479-84.
The chelation of mercury by 2,3-dimercaptopropane-1-sulfonate (DMPS) and its usefulness in the estimation of mercury burdens was investigated by exposing male, Sprague-Dawley rats to 203HgCl2 (0.1-2 mg of Hg per kg i.p.) or 203Hg vapor (0.5-2.0 mg of Hg per m3). DMPS (0.2-2.0 mmol/kg) was injected i.p. at times ranging from 1 to 38 days after exposure to the mercurial. Urine and feces were collected for 24 hr before and after DMPS treatment. Whole body mercury levels, tissue levels and excretion of mercury were measured by radioactivity counting. After DMPS treatment there was a significant decrease of whole body mercury levels and an increase in urinary excretion. The increase in urinary excretion was directly proportional to the whole body burden of mercury at the time of dosing with DMPS in animals dosed with HgCl2 and exposed to mercury vapor. Furthermore, the increase in urinary excretion induced by DMPS was almost equal to the amount of mercury lost from the kidneys.
通过给雄性斯普拉格-道利大鼠腹腔注射203HgCl2(每千克0.1 - 2毫克汞)或暴露于203Hg蒸汽(每立方米0.5 - 2.0毫克汞),研究了2,3 - 二巯基丙烷 - 1 - 磺酸盐(DMPS)对汞的螯合作用及其在评估汞负荷中的效用。在接触汞剂后1至38天的不同时间,腹腔注射DMPS(0.2 - 2.0毫摩尔/千克)。在DMPS治疗前后各收集24小时的尿液和粪便。通过放射性计数测量全身汞水平、组织汞水平和汞排泄情况。DMPS治疗后,全身汞水平显著降低,尿排泄增加。在给予HgCl2并暴露于汞蒸汽的动物中,尿排泄的增加与给药时DMPS处理时的全身汞负荷成正比。此外,DMPS引起的尿排泄增加几乎等于肾脏中损失的汞量。